ӢQ:(N-(3-TRIFLUOROMETHYL)BENZENESULFONYL)ALANINEӢͬx~:2-[3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE]PROPIONICACID;2-[3-(Trifluoromethyl)benzenesulphonamido]propionicacid97%
؛̖ | Ҏ(gu) | (sh) | r |
---|---|---|---|
Q-0098984 | 100mg |
1
|
ԃr |
Q-0098984 | 250mg |
1
|
ԃr |
Q-0098984 | 500mg |
1
|
ԃr |
Q-0098984 | 1g |
1
|
ԃr |
Q-0098984 | 5g |
1
|
ԃr |

(N-(3-))Q
(N-(3-))
Ӣ 2-[[3-(trifluoromethyl)phenyl]sulfonylamino]propanoic acid
Ąe N-[3-()]
(N-(3-))W(xu)|(zh)
ܶ 1.474g/cm3
c(din) 421.8ºC at 760mmHg
c(din) 123-125ºC
ʽ C10H10F3NO4S
297.25100
Wc(din) 208.9ºC
|(zh) 297.02800
PSA 91.85000
LogP 2.92850
;
B(ti)w/ĩ/Һ
a(chn)أ
rg1
棺
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖ | N/A |
N/A | |
l | -20ܹⱣ |
rg | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
ӢQ:SodiumhypophosphiteӢͬx~:Phosphinicacid,sodiumsalt;phosphinicacidmonosodiumsalt;sodiumhydrogenphosphite(nah2po2);sodiumhydrophosphite
-
ӢQ:Androst-2-en-17-oneӢͬx~:OCCLESTERONE;16-[5ALPHA]ANDROSTEN-3-ONE;16,(5A)-ANDROSTEN-3-ONE;17-oxo-5a-androst-2-ene